How do we know that #lupus is causing neuropsychiatric symptoms? In part 2 of our series “Neuropsychiatric Lupus: 4 Questions with Dr. Meggan Mackay”, rheumatologist and LRA-funded researcher Dr. Mackay answers this question. Watch to learn more! #InternationalQualityofLifeMonth

We're honored to announce the George & Maria Tsokos Endowed Recruitment Fund! Thanks to Drs. Tsokos’ generosity, this fund will inspire students & residents to explore #rheumatology through real-world learning. Join us in celebrating their impact! rheumresearch.org/Tsokos-Endowed…

Unwind at Toronto’s Harbourfront During #LUPUS2025! Take in stunning lake views, visit the Toronto Music Garden, or catch a ferry to the Islands for a peaceful escape—all just minutes from downtown! 📍 Plan your visit: bit.ly/4goAoac #Rheumatology #MedEd #VisitToronto

Exciting breaking news: A paper published today in the highly prestigious journal New England Journal of Medicine and presented at the World Congress of Nephrology reported that results of the Phase III REGENCY trial found that among people with active lupus nephritis, Gazyva®

With great pleasure, we organize, for one more year, the 2nd Greek Congress for SpA, with distinguished national and international speakers! spondyloarthritis.gr Stefan Siebert Armen Yuri Gasparyan Olena Zimba Maria Tektonidou rheum_appk Christos Koutsianas ImmunRheumGr Konstantinos Thomas

📝 A new study published in the NEJM shows addition of obinutuzumab to standard therapy may offer a viable treatment option for patients with lupus nephritis and high disease activity. More news: lupushub.com #Lupus #MedNews #MedEd

Have you seen our SLE webinar lineup? Our 'Advances in the treatment of SLE' webinar will feature talks from Professors Ed Vital, Cynthia Aranow, and Richard Furie. Don't miss out; register now! 🔗ow.ly/TtYv50VbBx2

I definitely recommend reading this piece!

On this World Young Rheumatic Diseases Day, let's raise awareness that rheumatic diseases can affect people of all ages, including children and young adults. Let’s advocate for better support, and ensure no young person faces this journey alone.💪✨ #3TR #RA #WORDDay2025

Tissue matters! sciencedirect.com/science/articl… #lupusnephritis #lupus #SLE #rheumatology Maria Tektonidou Brad H Rovin Hans-Joachim Anders Parodis lab SLEuro Lupus Europe

As a type II anti-CD20 monoclonal antibody, obinutuzumab depletes B cells more effectively than rituximab by enhancing ADCC and reducing internalisation. View the full slide summary here ow.ly/6N4S50Vy7Qy

Three weeks to go, don't miss out! There is still time to register, secure your spot, and gain insights into 'Advances in Lupus Nephritis'. 🎟️ow.ly/Myis50Vxcyq

🔬 What role does interferon play in #lupus? Join us on 23 May at #LUPUS2025 for a deep dive into the science behind SLE with leading experts including Mary K. Crow & Deepak Rao. 🕥 10:40–12:10 | Metropolitan West Don’t miss it: bit.ly/42BTPrd #LupusCare #LupusResearch

👉 Our April literature search identified 243 new papers on #Lupus! View the results by clicking the link below: 🔗ow.ly/kiTS50Vj2o2

New on the #3TR website: our section on patient-reported outcomes (PROs) is now live! 🎉💻 💡Discover why #PROs matter in improving patient care and how 3TR is contributing to this vital field. 🔗 Explore more here: 3tr-imi.eu/research/patie… #3TR #PatientCentredCare #PROs

Following the launch of our new #3TR website section on #PROs, we’re excited to share the first interview! Dr Graham Roberts, Professor at University of Southampton, explains why PROs are key to developing better therapies for #asthma. 💡 Watch the interview here: 3tr-imi.eu/research/patie…

Great work! Florian Tran 👏

📢 Congress Announcement 📢 We are pleased to announce that we will be in Toronto, Canada from 21st–24th May for the 16th International Congress on SLE Lupus 2025 You'll be able to find us at booth 18, if you're attending; we hope to see you there! #LUPUS2025 #LupusResearch

Just 2 weeks until #LUPUS2025 begins! ⏳ Get ready for groundbreaking sessions and networking in Toronto from May 21-24, 2025. ✅ Register now: bit.ly/3EpftXR #LupusResearch #Rheumatology #MedicalEvents

Subclinical #Atherosclerosis Risk Can Be Predicted in Female Patients With #SLE Using #Metabolomic Signatures pubmed.ncbi.nlm.nih.gov/40194967/